Reena Thomas, MD
Family Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Thomas’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C171530 · Current
Licensed to practise in California · since 2021 · expires 2027-02-28 · Ross University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Medicaid work
$17,755 in 2022
Medicaid paid $17,755 for 1,947 billed services this clinician did in 2022, up to 80 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 679 | $15,132 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 16 | $840 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 73 | $598 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $330 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 12 | $326 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 52 | $319 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 15 | $126 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 14 | $74 |
| Pain severity quantified; no pain present (COA) (ONC) | 475 | $10 |
| Advance care planning discussion documented in the medical record (COA) | 13 | $0 |
| BODY MASS INDEX DOCD | 512 | $0 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 72 | $0 |
| 2022 | 1,947 | 12 | 80 | $17,755 |
| 2021 | 3,583 | 15 | 79 | $115,405 |
| 2020 | 3,142 | 12 | 76 | $103,544 |
| 2019 | 3,179 | 14 | 107 | $47,675 |
| 2018 | 531 | 6 | 56 | $16,459 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 1,570 | $97,604 |
| Return visit (30+ min) | 114 | $7,724 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 90 | $6,711 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 109 | $966 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 25 | $821 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 94 | $709 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 127 | $621 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 13 | $122 |
| Pain severity quantified; no pain present (COA) (ONC) | 621 | $65 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 56 | $33 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 15 | $20 |
| Medication list documented in medical record (COA) | 24 | $5 |
2020
| Short return visit (20+ min) | 1,522 | $92,606 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 75 | $5,238 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 39 | $2,601 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 97 | $1,161 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 150 | $921 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 115 | $395 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use | 50 | $339 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 18 | $244 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 30 | $27 |
| Pain severity quantified; no pain present (COA) (ONC) | 467 | $12 |
| Pain severity quantified; pain present (COA) (ONC) | 29 | $0 |
| BODY MASS INDEX DOCD | 550 | $0 |
2019
| Short return visit (20+ min) | 1,092 | $40,674 |
| Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use | 27 | $1,770 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 123 | $1,657 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 172 | $1,383 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 121 | $795 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 36 | $567 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 55 | $494 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 13 | $125 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use | 12 | $95 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 76 | $59 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 647 | $32 |
| Pain severity quantified; no pain present (COA) (ONC) | 224 | $23 |
2018
| Short return visit (20+ min) | 310 | $16,296 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 15 | $105 |
| Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use | 13 | $57 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 69 | $2 |
| Pain severity quantified; no pain present (COA) (ONC) | 19 | $0 |
| BODY MASS INDEX DOCD | 105 | $0 |
Drugs they prescribed that Part D paid
$31,864
Pharmacies billed $31,864 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (11 of 757) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
679 generic and fewer than 11 brand-name prescriptions · $31,864 in drug cost · 22 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pradaxa | 13 | $3,284 | $253 |
| Atorvastatin | 87 | $1,092 | $13 |
| Amlodipine Besylate | 56 | $649 | $12 |
| Levothyroxine | 33 | $596 | $18 |
| Losartan | 47 | $531 | $11 |
See all 21 drugs
| Pradaxa | 13 | $3,284 | $253 |
| Atorvastatin | 87 | $1,092 | $13 |
| Amlodipine Besylate | 56 | $649 | $12 |
| Levothyroxine | 33 | $596 | $18 |
| Losartan | 47 | $531 | $11 |
| Albuterol Sulfate Hfa | 28 | $454 | $16 |
| Gabapentin | 15 | $344 | $23 |
| Warfarin | 20 | $320 | $16 |
| Hydralazine | 22 | $316 | $14 |
| Pregabalin | 15 | $274 | $18 |
| Lisinopril | 23 | $258 | $11 |
| Alendronate | 26 | $258 | $10 |
| Tamsulosin | 18 | $200 | $11 |
| Metformin | 16 | $197 | $12 |
| Hydrochlorothiazide | 17 | $184 | $11 |
| Metoprolol | 15 | $179 | $12 |
| Pantoprazole | 14 | $170 | $12 |
| Omeprazole | 13 | $145 | $11 |
| Famotidine | 11 | $132 | $12 |
| Metformin Hcl Er | 11 | $73 | $7 |
| Atenolol | 11 | $67 | $6 |
Year by year
| 2024 | 757 | 114 | 2% (11) | None | $31,864 |
| 2023 | 165 | 64 | 0% (0) | None | $15,466 |
| 2022 | 1,729 | 123 | 0% (0) | 19% | $217,549 |
| 2021 | 1,879 | 128 | 0% (0) | 14% | $132,615 |
| 2020 | 2,007 | 137 | 0% (0) | 16% | $131,970 |
| 2019 | 1,045 | 110 | 0% (0) | 15% | $51,418 |
| 2018 | 81 | 41 | 0% (0) | 35% | $7,908 |
| 2017 | 86 | 58 | 0% (0) | None | $4,223 |
| 2016 | 233 | 94 | 0% (0) | None | $13,696 |
| 2015 | 83 | 30 | 0% (0) | 18% | $6,396 |
| 2014 | 118 | 29 | 0% (0) | None | $5,027 |
| 2013 | 84 | 27 | None | None | $4,882 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Atorvastatin | 20 | $341 | $17 |
| Amlodipine Besylate | 12 | $156 | $13 |
2022: 32 drugs
| Januvia | 75 | $68,194 | $909 |
| Jardiance | 33 | $34,608 | $1,049 |
| Janumet | 20 | $17,672 | $884 |
| Basaglar Kwikpen U-100 | 18 | $7,393 | $411 |
| Novolog Flexpen | 12 | $7,088 | $591 |
| Symbicort | 17 | $6,505 | $383 |
| Advair Diskus | 12 | $4,998 | $416 |
| Breo Ellipta | 11 | $4,464 | $406 |
| Atorvastatin | 241 | $3,345 | $14 |
| Albuterol Sulfate Hfa | 83 | $2,866 | $35 |
| Ezetimibe | 85 | $1,955 | $23 |
| Amlodipine Besylate | 148 | $1,205 | $8 |
| Metoprolol | 40 | $806 | $20 |
| Losartan | 88 | $792 | $9 |
| Rosuvastatin | 47 | $712 | $15 |
| Metformin | 66 | $646 | $10 |
| Hydralazine | 29 | $584 | $20 |
| Nifedipine Er | 17 | $549 | $32 |
| Lisinopril | 64 | $508 | $8 |
| Diltiazem 24hr Er (Cd) | 11 | $339 | $31 |
| Omeprazole | 26 | $327 | $13 |
| Simvastatin | 41 | $281 | $7 |
| Levothyroxine | 15 | $215 | $14 |
| Gabapentin | 15 | $184 | $12 |
| Metoprolol | 18 | $151 | $8 |
| Carvedilol | 42 | $148 | $4 |
| Hydrochlorothiazide | 43 | $138 | $3 |
| Alcohol Prep Pads | 41 | $135 | $3 |
| Propranolol | 11 | $122 | $11 |
| Metformin Hcl Er | 12 | $110 | $9 |
| Clopidogrel | 13 | $74 | $6 |
| Easy Touch Alcohol Prep Pads | 11 | $31 | $3 |
2021: 34 drugs
| Januvia | 69 | $48,102 | $697 |
| Janumet | 11 | $12,759 | $1,160 |
| Lantus Solostar | 13 | $5,816 | $447 |
| Basaglar Kwikpen U-100 | 13 | $4,338 | $334 |
| Flovent Hfa | 12 | $2,661 | $222 |
| Atorvastatin | 275 | $2,573 | $9 |
| Albuterol Sulfate Hfa | 62 | $2,548 | $41 |
| Ezetimibe | 54 | $1,691 | $31 |
| Rosuvastatin | 51 | $1,604 | $31 |
| Losartan | 104 | $1,406 | $14 |
| Amlodipine Besylate | 191 | $763 | $4 |
| Nifedipine Er | 24 | $692 | $29 |
| Metoprolol | 42 | $613 | $15 |
| Metformin | 52 | $525 | $10 |
| Lisinopril | 84 | $490 | $6 |
| Pantoprazole | 19 | $289 | $15 |
| Gabapentin | 26 | $259 | $10 |
| Metoprolol | 27 | $249 | $9 |
| Metformin Hcl Er | 28 | $213 | $8 |
| Omeprazole | 37 | $212 | $6 |
| Spironolactone | 13 | $210 | $16 |
| Hydrochlorothiazide | 62 | $203 | $3 |
| Quinapril | 12 | $194 | $16 |
| Atenolol | 12 | $188 | $16 |
| Unifine Pentips | 12 | $179 | $15 |
| Simvastatin | 46 | $153 | $3 |
| Alcohol Prep Pads | 54 | $141 | $3 |
| Fluticasone Propionate | 12 | $138 | $11 |
| Carvedilol | 42 | $127 | $3 |
| Isosorbide Mononitrate Er | 12 | $48 | $4 |
| Tamsulosin | 13 | $47 | $4 |
| Lisinopril-Hydrochlorothiazide | 11 | $30 | $3 |
| Furosemide | 11 | $28 | $3 |
| Cyclobenzaprine | 11 | $12 | $1 |
2020: 37 drugs
| Januvia | 78 | $48,917 | $627 |
| Janumet | 30 | $18,211 | $607 |
| Trulicity | 12 | $10,069 | $839 |
| Flovent Hfa | 20 | $5,291 | $265 |
| Symbicort | 14 | $5,237 | $374 |
| Albuterol Sulfate Hfa | 51 | $2,255 | $44 |
| Atorvastatin | 320 | $2,139 | $7 |
| Fluticasone-Salmeterol | 11 | $1,983 | $180 |
| Rosuvastatin | 23 | $1,093 | $48 |
| Acarbose | 31 | $828 | $27 |
| Losartan | 105 | $759 | $7 |
| Amlodipine Besylate | 224 | $696 | $3 |
| Metoprolol | 35 | $655 | $19 |
| Nifedipine Er | 24 | $474 | $20 |
| Metformin | 103 | $419 | $4 |
| Lisinopril | 96 | $407 | $4 |
| Levothyroxine | 22 | $405 | $18 |
| Alcohol Prep Pads | 49 | $370 | $8 |
| Fluticasone Propionate | 26 | $304 | $12 |
| Enalapril Maleate | 16 | $246 | $15 |
| Hydrochlorothiazide | 63 | $235 | $4 |
| Unifine Pentips | 11 | $232 | $21 |
| Memantine | 13 | $201 | $15 |
| Metformin Hcl Er | 39 | $181 | $5 |
| Omeprazole | 22 | $171 | $8 |
| Spironolactone | 19 | $169 | $9 |
| Simvastatin | 48 | $151 | $3 |
| Labetalol | 11 | $145 | $13 |
| Gabapentin | 22 | $137 | $6 |
| Carvedilol | 28 | $132 | $5 |
| Atenolol | 29 | $128 | $4 |
| Lisinopril-Hydrochlorothiazide | 26 | $83 | $3 |
| Metoprolol | 27 | $80 | $3 |
| Furosemide | 17 | $47 | $3 |
| Lovastatin | 13 | $46 | $4 |
| Easy Touch Alcohol Prep Pads | 14 | $41 | $3 |
| Single Use Swab | 17 | $36 | $2 |
2019: 23 drugs
| Januvia | 26 | $12,858 | $495 |
| Atorvastatin | 160 | $1,668 | $10 |
| Proair Hfa | 22 | $1,544 | $70 |
| Albuterol Sulfate Hfa | 17 | $859 | $51 |
| Amlodipine Besylate | 110 | $348 | $3 |
| Losartan | 55 | $320 | $6 |
| Levothyroxine | 11 | $273 | $25 |
| Metformin | 65 | $260 | $4 |
| Lisinopril | 60 | $238 | $4 |
| Omeprazole | 23 | $204 | $9 |
| Nifedipine Er | 11 | $163 | $15 |
| Simvastatin | 25 | $146 | $6 |
| Metoprolol | 16 | $137 | $9 |
| Hydrochlorothiazide | 31 | $102 | $3 |
| Fluticasone Propionate | 14 | $97 | $7 |
| Lovastatin | 11 | $77 | $7 |
| Tamsulosin | 12 | $74 | $6 |
| Atenolol | 13 | $57 | $4 |
| Escitalopram | 12 | $47 | $4 |
| Carvedilol | 11 | $45 | $4 |
| Single Use Swab | 17 | $37 | $2 |
| Metoprolol | 12 | $34 | $3 |
| Alcohol Prep Pads | 11 | $26 | $2 |
2017: 1 drug
| Amoxicillin-Clavulanate Potass | 14 | $131 | $9 |
2016: 3 drugs
| Atorvastatin | 20 | $160 | $8 |
| Fluticasone Propionate | 12 | $115 | $10 |
| Hydrochlorothiazide | 24 | $69 | $3 |
2014: 2 drugs
| Levothyroxine | 11 | $119 | $11 |
| Simvastatin | 18 | $97 | $5 |
2013: 1 drug
| Simvastatin | 12 | $77 | $6 |
Money from drug and device companies
$875 in 2022
| 2022 | 8 | 25 | None | $875 |
| 2021 | 2 | 6 | None | $232 |
| 2020 | 1 | 4 | None | $62 |
| 2019 | 2 | 4 | None | $229 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Rybelsus | $452 | 8 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $278 | 10 payments
|
| GlaxoSmithKline | Shingrix | $39 | 2 payments
|
| Dynavax Technologies | Heplisav-B | $26 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Global Blood Therapeutics | Oxbryta | $20 | 1 payment
|
See all 25 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2022-10-24 | Farxiga | $21 |
| Novo Nordisk | Meals · 2022-10-18 | Rybelsus | $122 |
| Novo Nordisk | Meals · 2022-09-27 | Ozempic | $21 |
| GlaxoSmithKline | Meals · 2022-09-27 | Shingrix | $17 |
| Dynavax Technologies | Meals · 2022-09-21 | Heplisav-B | $26 |
| Teva Pharmaceuticals USA | Meals · 2022-09-13 | Austedo | $19 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-08-26 | Nurtec Odt | $10 |
| Mannkind | Meals · 2022-08-09 | Afrezza | $19 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-08-02 | Nurtec Odt | $17 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-08-02 | Nurtec Odt | $2 |
| Novo Nordisk | Meals · 2022-07-25 | Rybelsus | $125 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-07-06 | Nurtec Odt | $23 |
| Novo Nordisk | Meals · 2022-06-14 | Ozempic | $21 |
| Novo Nordisk | Meals · 2022-05-12 | Ozempic | $20 |
| Novo Nordisk | Meals · 2022-04-06 | Ozempic | $122 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-03-30 | Nurtec Odt | $11 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-03-25 | Nurtec Odt | $6 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-03-16 | Nurtec Odt | $139 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-03-14 | Nurtec Odt | $21 |
| Novo Nordisk | Meals · 2022-03-03 | Rybelsus | $3 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-02-28 | Nurtec Odt | $23 |
| GlaxoSmithKline | Meals · 2022-02-24 | Shingrix | $22 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-02-16 | Nurtec Odt | $25 |
| Novo Nordisk | Meals · 2022-02-10 | Rybelsus | $18 |
| Global Blood Therapeutics | Meals · 2022-02-03 | Oxbryta | $20 |
See earlier years (2021, 2020, 2019)
2021: $232
| Global Blood Therapeutics | Oxbryta | $209 | 5 payments
|
| GlaxoSmithKline | Shingrix | $23 | 1 payment
|
2020: $62
| GlaxoSmithKline | Shingrix | $62 | 4 payments
|
2019: $229
| GlaxoSmithKline | Bexsero | $211 | 3 payments
|
| Novo Nordisk | Ozempic | $18 | 1 payment
|
Professional record
- NPI
- 1871936534
- Licence
- CA 171530, NY 285092-1California C171530: Current · expires 2027-02-28
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2013-04-12
- NPI last updated
- 2023-09-17
- NPI record certified
- 2023-09-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 833 Manhattan Ave, Brooklyn, NY, 11222 · 1351 Washington Blvd, Stamford, CT, 06902
This office lists an electronic records connection.